Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 12/20 | 0.48 |
| ▸ | CPT2 | P23786 | 1/20 | 0.45 |
| ▸ | CPT1A | P50416 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24710613 | 0.82 | FKBP1A (0.65) | FKBP1APOLBSIGMAR1MEN1KMT2A | |
| SCHEMBL13099455 | 0.79 | FKBP1A (0.60) | FKBP1APOLBCHRNB2CHRNA5CHRNA7 | |
| SCHEMBL26291061 | 0.79 | FKBP1A (0.60) | FKBP1APOLBCHRNB2CHRNA5CHRNA7 | |
| SCHEMBL12869918 | 0.79 | FKBP1A (0.60) | FKBP1APOLBCHRNB2CHRNA5CHRNA7 | |
| SCHEMBL28066919 | 0.75 | FKBP1A (0.51) | FKBP1ACPT2CPT1APOLBSIGMAR1 | |
| SCHEMBL21271418 | 0.75 | FKBP1A (0.51) | FKBP1ACPT2CPT1APOLBSIGMAR1 | |
| SCHEMBL12733402 | 0.75 | SIGMAR1 (0.48) | FKBP1ACPT2CPT1APOLBSIGMAR1 | |
| SCHEMBL8475310 | 0.73 | FKBP1A (0.56) | FKBP1A | |
| SCHEMBL30612528 | 0.73 | FKBP1A (0.60) | FKBP1APOLBSIGMAR1CHRNB2CHRNA5 | |
| SCHEMBL29148077 | 0.72 | ALDH1A1 (0.52) | POLBMEN1KMT2ACHRNB2CHRNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3733648-B1 | METHOD FOR PREPARING 5R-BENZYLOXYAMINOPIPERIDIN-2S-CARBOXYLIC ACID OR DERIVATIVE THEREOF | XINFA PHARMACEUTICAL CO LTD (CN) | 2022-06-08 | — | — | EP | disclosed |
| US-20210323920-A1 | METHOD OF PREPARING 5R-[(BENZYLOXY) AMINO] PIPERIDINE-2S-CARBOXYLIC ACID OR A DERIVATIVE THEREOF | XINFA PHARMACEUTICAL CO., LTD (CN) | 2021-10-21 | — | — | US | disclosed |
| US-11142499-B1 | Method of preparing 5R-[(benzyloxy) amino] piperidine-2S-carboxylic acid or a derivative thereof | XINFA PHARMACEUTICAL CO., LTD (CN) | 2021-10-12 | — | — | US | disclosed |
| EP-3733648-A1 | METHOD FOR PREPARING 5R-BENZYLOXYAMINOPIPERIDIN-2S-CARBOXYLIC ACID OR DERIVATIVE THEREOF | Xinfa Pharmaceutical Co., Ltd (CN) | 2020-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11142499-B1 | Method of preparing 5R-[(benzyloxy) amino] piperidine-2S-carboxylic acid or a derivative thereof | GLUL, GRIN2D, GRIN2C | FKBP1A 4424/4885CPT2 1716/4885CPT1A 2379/4885 |
| US-20210323920-A1 | METHOD OF PREPARING 5R-[(BENZYLOXY) AMINO] PIPERIDINE-2S-CARBOXYLIC ACID OR A DERIVATIVE THEREOF | GLUL, GRIN2D, GRIN2C | FKBP1A 4424/4885CPT2 1716/4885CPT1A 2379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.